AiMediq specializes in developing advanced medical devices that leverage controlled hypoxia to deliver proven health benefits.
In 2024, AiMediq introduced the ReOxy® device, an innovative solution that provides personalized Intermittent Hypoxic–Hyperoxic Training (IHHT®). This unique therapy supports medical rehabilitation, enhances sports performance, and promotes healthy aging.
The ReOxy® device is a Class IIb medical device, meeting the highest standards of safety and efficacy. Our proprietary IHHT® method and our SRT® technology have been tested in numerous clinical trials across cardiology, pulmonology, sports medicine, and gerontology.
ReOxy® provides healthcare professionals with a reliable, evidence-based solution for improving patient outcomes through safe, non-invasive breathing therapy.
